Timing and Targeting of Cell-Based VEGF165 Gene Expression in Ischemic Tissue

Journal of Surgical Research

Volumn 151, Issue 1, 2009, Pages 153-162

  Spanholtz, Timo ^a,b   Maichle, Alexandra ^b   Niedworok, Christian ^b   Stoeckelhuber, Beate M ^a   Krüger, Stefan ^a   Wedel, Thilo ^a   Aach, Til ^a   Middeler, Guido ^e   Hellwig Bürgel, Thomas ^f   Bader, Augustinus ^g   Krengel, Sven ^a   Müller, Oliver J ^h   Franz, Wolfgang M ⁱ   Lindenmaier, Werner ^c   Machens, Hans Guenther ^b,d  

^a University Clinics Witten   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d KTE   (Germany)

^e Dr Middeler et al GmbH DiapharmGruppe   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

angiogenesis; gene transfer; tissue engineering; VEGF165

Indexed keywords

VASCULOTROPIN 165; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL BASED GENE THERAPY; CELL COUNT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; IMMUNOHISTOLOGY; ISCHEMIA; MICROANGIOGRAPHY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL;

ADENOVIRIDAE; ANIMALS; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; ISCHEMIA; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 57249084199     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.01.038     Document Type: Article

References (33)

1. Alessandri G., Emanueli C., and Madeddu P. Genetically engineered stem cell therapy for tissue regeneration. Ann NY Acad Sci 1015 (2004) 271
2. Betsholtz C., Lindblom P., Bjarnegard M., et al. Role of platelet-derived growth factor in mesangium development and vasculopathies: Lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr Opin Nephrol Hypertens 13 (2004) 45
3. Cao R., Brakenhielm E., Pawliuk R., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9 (2003) 604
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653
5. Lee R.J., Springer M.L., Blanco-Bose W.E., et al. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102 (2000) 898
6. Lei Y., Haider H., Shujia J., et al. Therapeutic angiogenesis. Devising new strategies based on past experiences. Basic Res Cardiol 99 (2004) 121
7. Liu Y., Sun L.J., Huan Y., et al. [The effect of basic fibroblast growth factor on angiogenesis and on the expression of basic fibroblast growth factor and vascular endothelial growth factor in acute infarcted myocardium]. Zhonghua Yi Xue Za Zhi 84 (2004) 54
8. Zisch A.H., Lutolf M.P., and Hubbell J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12 (2003) 295
9. Wickham T.J., Tzeng E., Shears II L.L., et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 71 (1997) 8221
10. Machens H.G., Grzybowski S., Bucsky B., et al. A technique to detect and to quantify fasciocutaneous blood vessels in small laboratory animals ex vivo. J Surg Res 131 (2006) 91
11. Mitani K., and Kubo S. Adenovirus as an integrating vector. Curr Gene Ther 2 (2002) 135
12. Middeler G., and Machens H.G. [Commentary on the article of A. Pruss and R. von Versen: Influence of European regulations on quality, safety and availability of cell and tissue allografts in Germany]. Handchir Mikrochir Plast Chir 39 (2007) 88
13. Yla-Herttuala S., Markkanen J.E., and Rissanen T.T. Gene therapy for ischemic cardiovascular diseases: Some lessons learned from the first clinical trials. Trends Cardiovasc Med 14 (2004) 295
14. Lu Y., Shansky J., Del Tatto M., et al. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104 (2001) 594
15. von Degenfeld G., Banfi A., Springer M.L., et al. Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. Br J Pharmacol 140 (2003) 620
16. Askari A., Unzek S., Goldman C.K., et al. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol 43 (2004) 1908
17. Sundberg C., Nagy J.A., Brown L.F., et al. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158 (2003) 1145
18. Hisaka Y., Ieda M., Nakamura T., et al. Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase. J Am Coll Cardiol 43 (2004) 1915
19. Hattan N., Warltier D., Gu W., et al. Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth. Am J Physiol Heart Circ Physiol 287 (2004) H488
20. Forough R., Wang X., Martinez-Lemus L.A., et al. Cell-based and direct gene transfer-induced angiogenesis via a secreted chimeric fibroblast growth factor-1 (sp-FGF-1) in the chick chorioallantoic membrane (CAM). Angiogenesis 6 (2003) 47
21. Schwarz E.R., Speakman M.T., Patterson M., et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. J Am Coll Cardiol 35 (2000) 1323
22. St George J.A. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 10 (2003) 1135
23. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 200 (2002) 575
24. Giunta R.E., Holzbach T., Taskov C., et al. AdVEGF165 gene transfer increases survival in overdimensioned skin flaps. J Gene Med 7 (2005) 297
25. Jung H., Gurunluoglu R., Scharpf J., et al. Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery 23 (2003) 374
26. Lubiatowski P., Goldman C.K., Gurunluoglu R., et al. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 109 (2002) 1986
27. Ozawa C.R., Banfi A., Glazer N.L., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113 (2004) 516
28. Richardson T.P., Peters M.C., Ennett A.B., et al. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 (2001) 1029
29. Cao R., Eriksson A., Kubo H., et al. Comparative evaluation of FGF-2- VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94 (2004) 664
30. Kondoh K., Koyama H., Miyata T., et al. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc Res 61 (2004) 132
31. Taverna S., Ghersi G., Ginestra A., et al. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278 (2003) 51911
32. Seghezzi G., Patel S., Ren C.J., et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141 (1998) 1659
33. Pajusola K., Kunnapuu J., Vuorikoski S., et al. Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 19 (2005) 1365